Ampliz vs Bytemine: Which B2B Data Provider Is Worth Your Budget?
"Ampliz vs Bytemine" sounds like a simple head-to-head. In practice, it's messy: one product has a clear niche and a real review footprint, and the other has an identity problem that makes basic due diligence harder than it should be.
Let's break it down like you'd do before you put either tool in front of RevOps, legal, or your CFO.
30-Second Verdict
Ampliz is the safer bet if you're selling into healthcare or building pipeline across APAC. It's positioned around APAC B2B intelligence and healthcare datasets, and it has real G2 validation plus a stated footprint of 400M+ B2B contacts across 16 APAC countries.
Bytemine.ai is an API-first enrichment option starting at $50/mo, and the pricing is attractive. But it has only one marketplace review on Datarade and constant brand confusion with a trading platform. For a data vendor, that's not a small issue - trust is the product.
Skip both if you need verified emails across industries at scale. Tools like Prospeo are built for that job: 300M+ profiles, 98% email accuracy, and a free tier, with data refreshed every 7 days. If you're doing outbound at volume, that freshness alone saves a lot of deliverability pain.
Quick Note: Bytemine.ai ≠ Bytemine.io (and not the G2 listing either)
This matters more than people think.
- On G2, the "Bytemine" listing is a brokerage/trading platform. Its alternatives page shows TradingView, eToro, and thinkorswim: https://www.g2.com/products/bytemine/competitors/alternatives
- Trustpilot's page for bytemine.io is also about trading algorithms and signals: https://www.trustpilot.com/review/bytemine.io
- The B2B data provider we're talking about here operates as Bytemine.ai and shows up on Datarade: https://datarade.ai/data-providers/bytemine/profile
If you're evaluating Bytemine.ai for enrichment, make sure procurement isn't accidentally reading reviews for a trading product. We've seen this exact mix-up happen in real vendor reviews, and it's a frustrating waste of time.
Feature-by-Feature Breakdown
| Feature | Ampliz | Bytemine.ai |
|---|---|---|
| Focus | APAC B2B + healthcare datasets | General B2B contact enrichment (API/datasets) |
| Database | 400M+ B2B contacts across 16 APAC countries | 80M mobiles, 70M+ work emails, 100M+ personal emails |
| Accuracy | Not publicly stated | 95% (listed on Datarade) |
| Starting price | $50/mo (100 credits) or $480/yr | $50/mo (self-serve) |
| Per-contact cost | Credit-based | $0.05/contact |
| Reviews | G2: 4.2/5 (7 reviews) | Datarade: 5.0/5 (1 review) |
| Best for | Healthcare targeting + APAC prospecting | Budget API enrichment workflows |
Both Ampliz and Bytemine start at $50/mo - but neither publicly commits to data freshness. Prospeo refreshes all 300M+ profiles every 7 days, delivers 98% email accuracy, and costs ~$0.01 per email. No trust gaps. No brand confusion. Just verified contacts that actually connect.
Stop debugging bounce rates. Start booking meetings.
Ampliz: The APAC + Healthcare Specialist
Ampliz is a specialist. That's good news if your ICP matches its strengths, and annoying if it doesn't.
If you're targeting healthcare professionals, provider networks, or APAC-based accounts where coverage is the whole point, Ampliz is built for that. It also supports bulk enrichment/cleaning workflows and common prospecting filters like industry, company size, location, and tech stack.
In our experience, specialists tend to feel "better than the big databases" inside their lane and noticeably thinner outside it. Ampliz fits that pattern. One G2 reviewer praised data quality for the DACH region and called out verified emails and direct dials as a bounce-rate reducer, but other reviewers flagged gaps once you move away from the tool's core use cases.
Where Ampliz feels strong
- Healthcare datasets (physicians/providers) and healthcare-adjacent targeting
- APAC prospecting where broad US-first databases often miss the mark
- Bulk enrichment/cleanup when you already know the segment you're after
Where it falls short (and yes, it can be annoying)
- Data can thin out for smaller and mid-sized companies in some markets
- Direct dials aren't consistently present
- The UI can feel dated, with too many clicks to refine searches and export
- Only 7 G2 reviews, so you're working with a small sample of public feedback
One reviewer put it bluntly: it "doesn't work for any other market except healthcare." That's not a deal-breaker if healthcare is your whole pipeline. If it's only 10% of your TAM, it's a warning label.
Bytemine.ai: Cheap API, Thin Trust
Bytemine.ai is the opposite of Ampliz in positioning. It's not trying to be a big prospecting UI with tons of filters. It's trying to be a straightforward enrichment API and dataset provider with self-serve pricing.
On paper, the offer is simple: $50/mo entry pricing, API access, and a per-contact cost listed at $0.05. The single Datarade review praises setup speed, documentation, and support responsiveness, which is exactly what you'd want to hear from an API-first vendor.
Here's the thing, though: for a data provider, trust isn't a "nice to have." It's the whole job.
Bytemine.ai has a trust deficit right now:
- One marketplace review total
- No meaningful third-party review footprint on the usual B2B software sites (and the G2 listing is for a different product category entirely)
- A 95% accuracy number shown on Datarade, but without independent validation attached
- The Datarade profile doesn't go deep on sourcing methodology
- Brand confusion between Bytemine.ai, bytemine.io, and the G2 trading listing makes due diligence harder than it should be
And look, this is where teams get burned: someone buys a "cheap enrichment API" to save money, then spends weeks debugging bounce rates, mismatched records, and inconsistent coverage. The invoice was small. The opportunity cost wasn't.
A quick scenario we see a lot
An agency grabs an API plan, wires it into a Clay/Zapier-style workflow, and starts enriching thousands of leads. Week one looks fine. Week two, deliverability starts sliding. Week three, the client asks why reply rates dropped and why the CRM is filling up with partial records. At that point, you're not "saving $200/mo." You're paying with pipeline.
If you're still considering Bytemine.ai, treat it like an experiment: run a tight pilot, measure match rate and bounce rate, and don't roll it into your core outbound motion until it earns that spot.
Which One Should You Pick?
Pick Ampliz if healthcare or APAC is central to your pipeline and you want a vendor with at least some public validation on a mainstream review site.
Pick Bytemine.ai only if you specifically want an API-first enrichment workflow, you're extremely price-sensitive, and you're willing to do real testing before you trust it in production.
One more opinionated note: both tools start at $50/mo, but neither makes a strong, explicit case (publicly) on data freshness. In 2026, freshness isn't a bonus feature. It's table stakes, because stale contact data quietly wrecks deliverability and wastes SDR hours.
A Stronger Third Option (Skip This Section If You're 100% Healthcare-Only)
If you're comparing Ampliz vs Bytemine because you need reliable, cross-industry prospecting and enrichment, you're probably in the wrong aisle. You don't need "a niche dataset" or "a cheap API." You need verified contacts, frequent refresh, and self-serve pricing that doesn't turn into an annual contract surprise.
Prospeo is built for that: 300M+ professional profiles, 143M+ verified emails, 125M+ verified mobile numbers, and 98% email accuracy. Data refresh runs on a 7-day cycle (the industry average is about 6 weeks), which is one of the fastest ways to reduce bounces without playing whack-a-mole in your sending setup.
It's also practical day-to-day: 30+ filters (including buyer intent across 15,000 topics powered by Bombora, technographics, and job-change signals), CRM and CSV enrichment that returns 50+ data points per contact, and an API with a 92% match rate. If you're trying to keep outbound clean while scaling, those details matter more than another "contacts count" claim on a landing page.
If you're wiring enrichment into Clay, Zapier, or your CRM, match rate is everything. Prospeo's API returns 92% match rates with 50+ data points per contact - plus 125M+ verified mobiles with a 30% pickup rate. No annual contracts, no 'talk to sales' gates.
Replace your unproven enrichment API with data that ships pipeline.
FAQ
Is Bytemine.ai the same as Bytemine on G2?
No. G2's "Bytemine" listing is a trading/brokerage product in financial services software: https://www.g2.com/products/bytemine/competitors/alternatives. The B2B data provider operates as Bytemine.ai and is listed on Datarade: https://datarade.ai/data-providers/bytemine/profile. Trustpilot's bytemine.io page is also about a trading product: https://www.trustpilot.com/review/bytemine.io.
Which tool is better for healthcare data?
Ampliz. It's positioned around healthcare datasets (including physician/provider data) and APAC B2B intelligence, while Bytemine.ai is a general-purpose enrichment API.
Is there a free tier for any of these tools?
Ampliz offers 10 free credits to start. Bytemine.ai doesn't show a free tier on its Datarade listing. Prospeo includes 75 free verified emails plus 100 Chrome extension credits per month with no credit card required.
What's the best alternative if neither Ampliz nor Bytemine fits?
If you need cross-industry coverage with high accuracy and frequent refresh, Prospeo is the stronger general-purpose option in this price range: 300M+ profiles, 98% email accuracy, and a 7-day refresh cycle, with self-serve pricing around $0.01 per email.